Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Kathryn A. Gold's publication output changed over time?
ScholarIQpublication output · 2013–2022
Output grew0% over the shown period — from 1 works in 2013 to 1 in 2022.
1
1
2
2
1
1
2
1
20132014201520162017201920212022
What are the most-cited papers on Kathryn A. Gold?
ScholarIQmost cited works
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang, Junya Fujimoto, Jianhua Zhang, David C. Wedge, Xingzhi Song, Jiexin Zhang, Sahil Seth, Chi‐Wan Chow, Yu Cao, Curtis Gumbs, Kathryn A. Gold, Neda Kalhor, Latasha Little, Harshad S. Mahadeshwar, César A. Moran, Alexei Protopopov, Huandong Sun, Jiabin Tang, Xifeng Wu, Yuanqing Ye, William N. William, J. Jack Lee, John V. Heymach, Waun Ki Hong, Stephen G. Swisher, Ignacio I. Wistuba, P. Andrew Futreal
Science. 20141,016 Citations
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Alice T. Shaw, Leena Gandhi, Shirish M. Gadgeel, Gregory J. Riely, Jeremy Cetnar, Howard West, D. Ross Camidge, Mark A. Socinski, Alberto Chiappori, Tarek Mekhail, Bo H. Chao, Hossein Borghaei, Kathryn A. Gold, Ali Zeaiter, Walter Bordogna, Bogdana Balas, Óscar Puig, Volkmar Henschel, Sai‐Hong Ignatius Ou
The Lancet Oncology. 2015641 CitationsOPEN ACCESS
Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
James Chih‐Hsin Yang, Myung‐Ju Ahn, Dong‐Wan Kim, Suresh S. Ramalingam, Lecia V. Sequist, Wu‐Chou Su, Sang-We Kim, Joo-Hang Kim, David Planchard, Enriqueta Felip, Fiona Blackhall, Daniel Haggstrom, Kiyotaka Yoh, Silvia Novello, Kathryn A. Gold, Tomonori Hirashima, Chia‐Chi Lin, Helen Mann, Mireille Cantarini, Serban Ghiorghiu, Pasi A. Jänne
Journal of Clinical Oncology. 2017577 CitationsOPEN ACCESS
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Martin Reck, Alexander Luft, Aleksandra Szczęsna, Libor Havel, Sang-We Kim, Wallace Akerley, M. Catherine Pietanza, Yi‐Long Wu, Christoph Zielinski, Michael J. Thomas, Enriqueta Felip, Kathryn A. Gold, Leora Horn, Joachim G.J.V. Aerts, Kazuhiko Nakagawa, Paul Lorigan, Anne Pieters, Teresa Kong Sanchez, Justin Fairchild, David R. Spigel
Journal of Clinical Oncology. 2016538 Citations
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor Ganti, Billy W. Loo, M. Bassetti, Collin M. Blakely, Anne C. Chiang, Thomas A. D’Amico, Christopher D’Avella, Afshin Dowlati, Robert J. Downey, Martin J. Edelman, Charles Florsheim, Kathryn A. Gold, Jonathan W. Goldman, J.C. Grecula, Christine L. Hann, Wade T. Iams, Puneeth Iyengar, Karen Kelly, Maya Khalil, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian R. Molina, César A. Moran, Saraswati Pokharel, Sonam Puri, Angel Qin, Chad G. Rusthoven, Jacob Sands, Rafael Santana-Dávila, Michael Shafique, Saiama N. Waqar, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 2021478 CitationsOPEN ACCESS
Related on ScholarIQ
UC San Diego Health System
Institution
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Paper
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Paper
Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
Paper
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Paper
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Paper